Frazis Capital Partners

The frontier of radiopharmaceuticals with research superstar Professor Louise Emmett

Opthea

March 2025 Strategy Update

March 2025 Strategy Update

February Market update

True customer love and explosive growth

Still works

Aussie unicorns

Open-weight vs open-source, new opportunities, and 2024 in review

DeepSeek Disruption

An interview with Ausbiz

January 2025 Investment Update

Orthocell, a conversation with CEO Paul Anderson

CEO Series

Syntara!

And our November investment update